Retour
Également cotée sous
RHHBY
OTC
Fourchette du Jour
378,00 €
386,75 €
Fourchette 52 Semaines
288,90 €
514,08 €
Volume
3
Moyenne 50J / 200J
450,02 €
/
384,75 €
Clôture Précédente
385,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 23,9 | 0,2 |
| P/B | 9,1 | 3,0 |
| ROE % | 39,3 | 3,6 |
| Net Margin % | 20,9 | 3,8 |
| Rev Growth 5Y % | -0,5 | 9,9 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
29,09 €
27,55 € – 30,81 €
|
77,62B | 1 |
| FY2029 |
25,94 €
24,58 € – 27,48 €
|
73,23B | 1 |
| FY2028 |
23,68 €
22,43 € – 25,08 €
|
68,97B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | 8,60 € | — |
| 2025-07-24 | 13,18 € | 5,81 € | -55,9% |
| 2025-01-30 | 9,25 € | 2,77 € | -70,1% |
| 2024-10-23 | 10,42 € | 8,71 € | -16,4% |
| 2024-04-26 | 10,07 € | 6,34 € | -37,0% |
| 2023-11-29 | 11,62 € | 9,90 € | -14,8% |
| 2023-02-02 | 9,49 € | 5,26 € | -44,6% |
| 2022-07-21 | 11,53 € | 10,99 € | -4,7% |
Dividend History
6 yr streakYield
0,03%
Payout Ratio
0,65%
Growth (3Y)
3,45%
Growth (5Y)
3,79%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 13, 2026 | Mar 16, 2026 | 13,74 € | 3,15% |
| Mar 28, 2025 | Mar 31, 2025 | 11,01 € | 3,13% |
| Mar 14, 2024 | Mar 18, 2024 | 10,87 € | 3,73% |
| Mar 16, 2023 | Mar 20, 2023 | 10,22 € | 3,34% |
| Mar 17, 2022 | Mar 21, 2022 | 9,95 € | 2,28% |
| Mar 18, 2021 | Mar 22, 2021 | 9,80 € | 2,87% |
| Mar 19, 2020 | Mar 23, 2020 | 9,14 € | 3,04% |
| Mar 07, 2019 | Mar 11, 2019 | 8,63 € | 3,25% |
| Mar 15, 2018 | Mar 19, 2018 | 8,73 € | 3,57% |
| Mar 16, 2017 | Mar 20, 2017 | 8,24 € | 3,21% |
| Mar 03, 2016 | Mar 07, 2016 | 8,16 € | 3,20% |
| Mar 05, 2015 | Mar 10, 2015 | 8,23 € | 3,11% |
| Mar 06, 2014 | Mar 11, 2014 | 8,85 € | 2,97% |
| Mar 07, 2013 | Mar 12, 2013 | 7,78 € | 3,16% |
| Mar 08, 2012 | Mar 13, 2012 | 7,49 € | 4,12% |
| Mar 03, 2011 | Mar 08, 2011 | 7,09 € | 4,60% |
| Mar 04, 2010 | Mar 09, 2010 | 5,58 € | 3,23% |
| Mar 16, 2009 | Mar 16, 2009 | 4,22 € | 3,12% |
| Mar 07, 2008 | Mar 07, 2008 | 4,49 € | 2,20% |
| Mar 08, 2007 | Mar 08, 2007 | 2,78 € | 1,35% |
Points Clés
Revenue declined -0,50% annually over 5 years
Earnings grew 55,69% over the past year
ROE of 39,30% indicates high profitability
Net margin of 20,94% shows strong profitability
Generating 14,09B in free cash flow
PEG of 0,39 suggests growth is underpriced
Croissance
Revenue Growth (5Y)
-0,50%
Revenue (1Y)-1,36%
Earnings (1Y)55,69%
FCF Growth (3Y)10,95%
Qualité
Return on Equity
39,30%
ROIC17,98%
Net Margin20,94%
Op. Margin26,59%
Sécurité
Debt / Equity
1,02
Current Ratio1,38
Interest Coverage12,13
Valorisation
P/E Ratio
23,89
Forward P/E19,09
P/B Ratio9,10
EV/EBITDA20,57
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,36% | Revenue Growth (3Y) | 0,91% |
| Earnings Growth (1Y) | 55,69% | Earnings Growth (3Y) | 5,86% |
| Revenue Growth (5Y) | -0,50% | Earnings Growth (5Y) | -1,93% |
| Profitability | |||
| Revenue (TTM) | 61,55B | Net Income (TTM) | 12,89B |
| ROE | 39,30% | ROA | 12,79% |
| Gross Margin | 72,94% | Operating Margin | 26,59% |
| Net Margin | 20,94% | Free Cash Flow (TTM) | 14,09B |
| ROIC | 17,98% | FCF Growth (3Y) | 10,95% |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 1,38 |
| Interest Coverage | 12,13 | ||
| Dividends | |||
| Dividend Yield | 0,03% | Payout Ratio | 0,65% |
| Dividend Growth (3Y) | 3,45% | Dividend Growth (5Y) | 3,79% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 23,89 | Forward P/E | 19,09 |
| P/B Ratio | 9,10 | P/S Ratio | 5,00 |
| PEG Ratio | 0,39 | Forward PEG | N/A |
| EV/EBITDA | 20,57 | Fwd EV/EBITDA | 16,09 |
| Forward P/S | 4,88 | Fwd Earnings Yield | 5,24% |
| FCF Yield | 4,58% | ||
| Market Cap | 307,85B | Enterprise Value | 336,72B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61,55B | 62,40B | 60,44B | 63,28B | 62,80B |
| Net Income | 12,89B | 8,28B | 11,50B | 12,42B | 13,93B |
| EPS (Diluted) | 16,05 | 10,32 | 14,30 | 15,37 | 16,20 |
| Gross Profit | 44,89B | 46,11B | 44,08B | 42,88B | 43,15B |
| Operating Income | 16,37B | 13,42B | 15,40B | 17,48B | 18,16B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 100,75B | 101,80B | 90,47B | 88,15B | 92,32B |
| Total Liabilities | 62,85B | 65,64B | 57,21B | 56,14B | 63,97B |
| Shareholders' Equity | 33,82B | 31,77B | 29,32B | 27,99B | 24,49B |
| Total Debt | 34,45B | 36,35B | 30,78B | 26,54B | 32,55B |
| Cash & Equivalents | 5,58B | 6,98B | 5,38B | 4,99B | 6,85B |
| Current Assets | 38,75B | 40,04B | 33,45B | 33,82B | 35,63B |
| Current Liabilities | 28,01B | 27,02B | 24,82B | 27,24B | 38,42B |